Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
First Solar
FSLR
|
+$24.3M |
| 2 |
Lamb Weston
LW
|
+$21.6M |
| 3 |
Ovintiv
OVV
|
+$21.3M |
| 4 |
Hubbell
HUBB
|
+$21.3M |
| 5 |
U-Haul Holding Co Series N
UHAL.B
|
+$19.6M |
Top Sells
| 1 |
Apple
AAPL
|
+$627M |
| 2 |
Microsoft
MSFT
|
+$479M |
| 3 |
Amazon
AMZN
|
+$203M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$169M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$150M |
Sector Composition
| 1 | Technology | 25.32% |
| 2 | Healthcare | 16.62% |
| 3 | Consumer Discretionary | 10.98% |
| 4 | Industrials | 9.74% |
| 5 | Consumer Staples | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Kaiser Aluminum
KALU
$1.24B
| $2.92M | ﹤0.01% |
38,500
+1,000
| +3% | +$76K |
|
|
FSR
1652
DELISTED
Fisker Inc.
FSR
| $2.92M | ﹤0.01% |
401,700
+10,800
| +3% | +$78.5K |
|
|
SVC
1653
Service Properties Trust
SVC
$476M
| $2.91M | ﹤0.01% |
398,788
+8,400
| +2% | +$61.2K |
|
1654
Pediatrix Medical
MD
$1.45B
| $2.88M | ﹤0.01% |
193,500
-2,900
| -1% | -$43.1K |
|
1655
ePlus
PLUS
$1.97B
| $2.87M | ﹤0.01% |
64,856
+1,500
| +2% | +$66.4K |
|
1656
Rhythm Pharmaceuticals
RYTM
$6.39B
| $2.85M | ﹤0.01% |
97,900
+8,300
| +9% | +$242K |
|
1657
Compass Diversified
CODI
$527M
| $2.84M | ﹤0.01% |
155,900
+6,100
| +4% | +$111K |
|
1658
Employers Holdings
EIG
$983M
| $2.84M | ﹤0.01% |
65,800
| – | – |
|
1659
HNI Corp
HNI
$2.07B
| $2.84M | ﹤0.01% |
99,800
-700
| -0.7% | -$19.9K |
|
|
EVBG
1660
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $2.84M | ﹤0.01% |
95,900
+2,100
| +2% | +$62.1K |
|
1661
Celestica
CLS
$27.8B
| $2.84M | ﹤0.01% |
251,700
| – | – |
|
1662
BGC Group
BGC
$4.82B
| $2.83M | ﹤0.01% |
751,008
+9,900
| +1% | +$37.3K |
|
1663
IAMGOLD
IAG
$6.42B
| $2.83M | ﹤0.01% |
1,104,000
+29,100
| +3% | +$74.6K |
|
1664
Myriad Genetics
MYGN
$674M
| $2.83M | ﹤0.01% |
194,700
+4,200
| +2% | +$60.9K |
|
1665
Astrana Health
ASTH
$1.38B
| $2.82M | ﹤0.01% |
95,344
+2,300
| +2% | +$68.1K |
|
1666
Primoris Services
PRIM
$6.59B
| $2.82M | ﹤0.01% |
128,500
+1,300
| +1% | +$28.5K |
|
1667
Relay Therapeutics
RLAY
$688M
| $2.82M | ﹤0.01% |
188,700
+3,800
| +2% | +$56.8K |
|
1668
TriMas Corp
TRS
$1.59B
| $2.81M | ﹤0.01% |
101,300
| – | – |
|
|
MYOV
1669
DELISTED
Myovant Sciences Ltd.
MYOV
| $2.81M | ﹤0.01% |
104,200
+2,500
| +2% | +$67.4K |
|
1670
Credo Technology Group
CRDO
$28B
| $2.81M | ﹤0.01% |
211,016
+142,816
| +209% | +$1.9M |
|
1671
XPEL
XPEL
$960M
| $2.8M | ﹤0.01% |
46,700
+1,100
| +2% | +$66.1K |
|
1672
Stewart Information Services
STC
$2.09B
| $2.79M | ﹤0.01% |
65,400
+1,300
| +2% | +$55.5K |
|
1673
Scholastic
SCHL
$691M
| $2.79M | ﹤0.01% |
70,600
+900
| +1% | +$35.5K |
|
1674
Kornit Digital
KRNT
$647M
| $2.77M | ﹤0.01% |
120,800
+2,700
| +2% | +$62K |
|
1675
Mativ Holdings
MATV
$674M
| $2.77M | ﹤0.01% |
132,612
+4,300
| +3% | +$89.9K |
|